A major public health concern has emerged after Haryana’s Food Safety Department confirmed that an infant milk powder sample from Nutrimed Healthcare—manufactured in Faridabad’s IMT area—has been officially deemed unsafe for consumption. The product is specifically designed for newborns aged up to six months, a highly vulnerable age group dependent on external nutrition. As the company distributes its formula across India and exports to nearly 20 countries, the findings have triggered widespread alarm among healthcare professionals, parents, and regulatory bodies. Many experts stress that any lapse in infant formula quality can pose severe and lasting developmental risks, making this case particularly critical.
Authorities reported that the contaminated sample was taken during routine Diwali festival inspections as part of a wider food-safety surveillance initiative. The subsequent laboratory analysis revealed violations of established nutritional and safety standards, particularly pointing to risks related to thyroid irregularities and improper weight gain in infants. Officials noted that weakened immunity associated with compromised formula compositions poses additional dangers, potentially exposing infants to infections and long-term health complications. Following confirmation of the report, the department promptly issued a formal notice to Nutrimed Healthcare, demanding a detailed explanation and initiating a deeper investigation into the company’s manufacturing practices and quality-control procedures.
Food Safety Department officer Prithvi Singh stated that 67 food samples were collected during festive checks, of which 18 have been tested so far, and three—including the Nutrimed product—were marked unsafe. According to Singh, the infant formula failed to meet legally mandated benchmarks outlined in the Food Safety and Standards Act. He emphasized that infant nutrition falls under a high-risk regulatory category due to the delicate nature of the target consumers, and any deviation warrants strict scrutiny. Singh further added that if the company’s justification is inadequate, the matter will move toward stringent legal action, potentially involving product recalls, fines, or criminal charges depending on the severity of violations.
Also Read: #JustIn: Widow Alleges IAS Officer, MLA Brother Pressured Haryana ASI Before Suicide, Demands CBI Probe
The revelations have sent shockwaves across the state and beyond, igniting fears among parents who rely on packaged formula for their newborns—especially those unable to breastfeed. Pediatricians and child-health advocates have expressed growing concern, urging caregivers to exercise caution and verify product labels, manufacturer credentials, and FSSAI license numbers before purchase. Public-health experts suggest this incident underscores the urgent need for strengthened monitoring of baby-nutrition products, given their critical impact on infant growth and cognitive development. Social-media platforms and parent-support groups have seen increased discussions, with many demanding transparency, accountability, and timely updates from authorities.
In response, Nutrimed Healthcare’s owner, T. N. Tiwari, dismissed the allegations and suggested that the situation may be influenced by competitive pressure from multinational brands. He asserted that the company maintains strict quality standards and has requested a re-inspection to verify product safety. The statement has, however, done little to quell concerns among families and health advocates, who insist that independent audits and government-led testing are essential to restoring public trust. As the investigation progresses, regulatory officials and medical experts emphasize that safeguarding infant nutrition remains paramount, and any breach will be dealt with utmost seriousness to ensure the well-being of the nation’s youngest citizens.
Also Read: Diwali's Toxic Legacy: Punjab & Haryana's AQI Plunges into 'Very Poor' Danger Zone